SCHEMBL2369946

SCHEMBL2369946

Cc1oc2cc([N+](=O)[O-])ccc2c1C(N)=O

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.51
LMNA P02545 2/20 0.51
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
MAPT P10636 1/20 0.50
TDP1 Q9NUW8 3/20 0.48
MAPK1 P28482 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
POLB P06746 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
CA12 O43570 2/20 0.45
CA9 Q16790 2/20 0.45
TSHR P16473 4/20 0.42
CYP3A4 P08684 2/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12218658 0.79 MEN1 (0.55) HTTLMNAKMT2AMEN1MAPT
SCHEMBL9277041 0.79 CA12 (0.60) LMNAKMT2AMEN1MAPTL3MBTL1
SCHEMBL13699679 0.75 NPC1 (0.55) LMNAKMT2AMEN1MAPTTDP1
SCHEMBL7703302 0.74 MEN1 (0.82) LMNAKMT2AMEN1MAPTTDP1
SCHEMBL6578120 0.73 CA12 (0.53) KMT2AMEN1MAPTPOLBCA12
SCHEMBL6578090 0.73 CA12 (0.64) HTTLMNAKMT2AMEN1MAPT
SCHEMBL2996087 0.73 CA12 (0.53) KMT2AMEN1MAPTPOLBCA12
SCHEMBL1919253 0.72 CYP2C19 (0.61) KMT2AMEN1POLBSMN1; SMN2CA12
SCHEMBL17364506 0.71 HTT (0.75) HTTLMNAMAPTTDP1MAPK1
SCHEMBL27905678 0.71 KMT2A (0.53) LMNAKMT2AMEN1MAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2545042-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Bristol-Myers Squibb Company (US) 2013-01-16 EP disclosed
WO-2011112191-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2011-09-15 WO disclosed